Mar. 8, 2026
Bronstein, Gewirtz & Grossman LLC Files Class Action Against Boston Scientific
Lawsuit alleges Boston Scientific misled investors about growth projections and headwinds in its electrophysiology segment.
Mar. 7, 2026
ROSEN Law Firm Encourages Boston Scientific Investors to Secure Counsel Before Deadline
Lawsuit alleges Boston Scientific misled investors about growth in its U.S. Electrophysiology segment
Mar. 5, 2026
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
Revenue reaches record $109.4 million, adjusted EBITDA hits $24.3 million for the full year
Mar. 5, 2026
Charles River Associates to Present at Sidoti Small-Cap Virtual Conference
CRA leadership to webcast and meet with investors at the March 18-19 event.
Mar. 5, 2026
Vicarious Surgical Faces NYSE Delisting Again
Surgical robot developer's stock suspended after falling below $15 million market cap threshold
Mar. 5, 2026
ARK Investment Boosts Stake in Toast
Firm increases position in restaurant tech company by nearly 10% in Q3
Mar. 5, 2026
Barrington Research Reiterates Outperform Rating for Charles River Associates
The global consulting firm specializing in economic, financial and management advisory services maintains its positive outlook.
Mar. 4, 2026
Moderna to Pay Up to $2.25B to Settle COVID Vaccine Patent Dispute
Moderna reaches deal with Genevant Sciences and Arbutus Biopharma over technology used in its COVID-19 vaccine.
Mar. 4, 2026
Nvidia's Physical AI Poised for Massive Growth by 2035
Nvidia's Rubin product line is designed to capitalize on agentic artificial intelligence, with potential for hundreds of billions in revenue from robotaxis and general robotics.
Mar. 4, 2026
Handelsbanken Fonder AB Increases Stake in Pegasystems Inc.
The Swedish investment firm raised its holdings in the software company by 45.3% in the third quarter.
Mar. 3, 2026
Senior Confirms All-Cash Takeover Bid from US Investor Consortium
Hertfordshire-based engineering firm receives offer as rival bidder Advent International also considers proposal
Mar. 2, 2026
Entrada Therapeutics Announces Inducement Grants
Biotech firm grants restricted stock units to new hires under Nasdaq rules
Mar. 2, 2026
Akebia Therapeutics Reports Inducement Grants
Biopharmaceutical company grants stock options to new hires under Nasdaq rule
Feb. 28, 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Sanjeev Luther, President and CEO, to provide corporate overview and business outlook
Feb. 28, 2026
Semrush and Information Analysis Compared: Which Tech Stock Reigns Supreme?
Analyzing the financial metrics and market performance of two small-cap computer and technology companies.
Feb. 27, 2026
Westfield Capital Management Boosts Synopsys Stake
Investment firm increases position in semiconductor design software company
Feb. 27, 2026
UBS Announces Changes to Board of Directors
Agustín Carstens and Luca Maestri nominated for election, Lukas Gähwiler to retire, William C. Dudley and Jeanette Wong to step down
Feb. 27, 2026
EverQuote Reports Record Q4 and Full-Year 2025 Results
Insurer expects 'stable and healthy' P&C market in 2026 as it accelerates AI adoption
Feb. 27, 2026
Relay Therapeutics to Announce Q4 and Full Year 2025 Results
The biotech company will report its latest financial performance next week.
Feb. 26, 2026
MDxHealth Reports Q4 Earnings, Highlights Continued Growth and Integration of ExoDx
Company sees revenue rise 19% in Q4, but operating and net losses widen amid ExoDx acquisition costs
